Intercept Pharma (ICPT) Miss Q4 Earnings

Intercept Pharmaceuticals, Inc. (ICPT) reported fourth quarter EPS of ($1.63) before the opening bell Monday, compared to the consensus estimate of ($1.62). Revenues decreased 11.1% from last year to $0.04 million. Analysts expected revenues of $0.42 million. For the full-year 2014, net loss attributable to common stockholders was $283.2 million, or $13.63 per share, compared […] View the full post at: Intercept Pharma (ICPT) Miss Q4 Earnings Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock After-Hours Earnings (March 9)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.